Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin plus Self-Compassion Training in Borderline Personality Disorder
2024-515589-15-00Phase 4Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in borderline personality disorder (BPD) comparing Oxytocin + Self-Compassion Training with Placebo + Self-Compassion Training (2 arms). Primary endpoint: Self-compassion/self-invalidation (SCS-SF). Planned start Jul 2024; status: authorised.
02
Drugs
oxytocin
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on 2024-515589-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515589-15-00.